CHRU Strasbourg - UMR CNRS 7021 unit
Pediatric glioma models - drug testing
I have expertise in the study of brain microenvironment with in vitro models combining normal brain cells and patient derived cell lines. Those specific models are important to design drug testing and work on hypoxic brain microenvironment present in normal brain and in tumor itself. My main topic is high grade glioma where hypoxia is playing a major role in blood-brain barrier adaptation and in tumor cell metabolism.
Existing collaborations relevant to drug delivery
Publications relevant to drug delivery
Email for contact details